Broader Horizons: Incorporating ART Advances Into Patient Care

Register now for this complimentary CME-certified symposium presented during the 17th European AIDS Conference.

In this highly interactive program, learn how newer ARV regimens fit into current HIV practice. A faculty panel will use case-based examples to explore first-line and switch options for commonly encountered clinical scenarios and the data that inform treatment selection. Each patient case, initially straightforward, will evolve to foster discussion on how complicating factors alter the management strategy.


4:15 PM - 4:20 PM Welcome and Introduction

4:20 PM - 4:40 PM Reviewing Recent Advances in ART

4:40 PM - 5:25 PM Expert Guidance on Selecting First-line Therapy and Switch Strategies: Case-Based Discussion

5:25 PM - 5:40 PM Question and Answer Session

5:40 PM - 5:45 PM Conclusions and Closing Thoughts


Date / Time
Event Details


Program Director
Jean-Michel Molina, MD, PhD

Head of the Department of Infectious Diseases
Saint-Louis Hospital, Assistance-Publique Hôpitaux de Paris
Paris, France
Professor of Infectious Diseases
University of Paris
Paris, France

José R. Arribas, MD

Research Director (HIV and Infectious Diseases)
Hospital La Paz. IdiPAZ.
Madrid, Spain

Alexandra Calmy, MD, FMH, PhD

HIV/AIDS Unit Director
Infectious Diseases Division
Geneva University Hospitals
University of Geneva
Geneva, Switzerland

Laura Waters, MD

Consultant Physician, HIV/GU Medicine
Mortimer Market Centre
London, United Kingdom

Goal Statement
The goal of this activity is to improve learners’ knowledge and competence regarding the integration of newer ARV regimens and paradigms into patient management strategies.

Target Audience
This program is intended for physicians and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives

  • Apply recent clinical trial data when devising patient care strategies that include newer ARV agents
  • Incorporate innovative ARV treatment strategies into the management of persons with HIV infection when appropriate
  • Appraise 2-drug vs 3-drug treatment strategies in the care of persons with HIV infection


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.